Science Explorer Back to mapMap
Discussion
Company · Winnipeg · Canada

Kane Biotech (Canada)

Research works
28
▲ 37% vs 2018-21
Citations
841
30.2 per fractional work
Top-10% rate
11.0%
all institutions 10.0%
Open access
64%
world 40%
International
38%
world 18%

Not ranked overall: Kane Biotech (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Kane Biotech (Canada) work in?

In all years, 51% of research at Kane Biotech (Canada) is in Life Sciences, 31% in Health Sciences. Its largest fields are Medicine (25%), Biochemistry, Genetics and Molecular Biology (24%), Chemistry (13%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 14 fractional works · 51.0% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 24.3% of its workMolecular Biology: 4 fractional works · 15.8% of its workBiotechnology: 1 fractional works · 4.7% of its workMolecular Medicine: 1 fractional works · 2.0% of its workCell Biology: 0 fractional works · 0.8% of its workEndocrinology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 11.5% of its workPharmaceutical Science: 2 fractional works · 7.6% of its workPharmacology: 1 fractional works · 2.4% of its workDrug Discovery: 0 fractional works · 1.2% of its workToxicology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 3 fractional works · 9.3% of its workFood Science: 1 fractional works · 3.9% of its workPlant Science: 1 fractional works · 3.6% of its workAquatic Science: 0 fractional works · 1.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 6.0% of its workMicrobiology: 1 fractional works · 3.8% of its workImmunology: 1 fractional works · 2.2% of its workHealth Sciences: 9 fractional works · 31.3% of its workMedicine: 7 fractional works · 24.7% of its workRehabilitation: 1 fractional works · 2.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.5% of its workOncology: 1 fractional works · 1.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.8% of its workComplementary and alternative medicine: 0 fractional works · 1.8% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.8% of its workEpidemiology: 0 fractional works · 1.8% of its workSurgery: 0 fractional works · 1.6% of its workBiochemistry: 0 fractional works · 1.5% of its workDermatology: 0 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.2% of its workInfectious Diseases: 0 fractional works · 1.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workDentistry: 1 fractional works · 5.1% of its workPeriodontics: 1 fractional works · 3.8% of its workOrthodontics: 0 fractional works · 1.0% of its workOral Surgery: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 1.2% of its workNutrition and Dietetics: 0 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.4% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workPhysical Sciences: 5 fractional works · 17.7% of its workChemistry: 4 fractional works · 13.2% of its workOrganic Chemistry: 4 fractional works · 13.0% of its workSpectroscopy: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.9% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.2% of its workEcology: 0 fractional works · 0.8% of its workMaterials Science: 0 fractional works · 1.5% of its workBiomaterials: 0 fractional works · 1.2% of its workSurfaces, Coatings and Films: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 1.0% of its workALL ITS WORKKane Biotech(Canada)28fractional works, all years
Life Sciences51%Physical Sciences18%Health Sciences31%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology724.3%
    2. Pharmacology, Toxicology and Pharmaceutics311.5%
    3. Agricultural and Biological Sciences39.3%
    4. Immunology and Microbiology26.0%
    1. Medicine724.7%
    2. Dentistry15.1%
    3. Nursing01.2%
    4. Health Professions00.4%
    1. Chemistry413.2%
    2. Environmental Science11.9%
    3. Materials Science01.5%
    4. Engineering01.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.55× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.22× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.56× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 63.44× its world share, 3 worksPharmacology, Toxico…Chemistry: 13.95× its world share, 3 worksChemistryMaterials Science: 0.80× its world share, 0 worksMaterials ScienceDentistry: 5.18× its world share, 0 worksDentistryMedicine: 1.20× its world share, 3 worksMedicineNursing: 5.70× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 63.4×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics63.44×3 works
  2. Chemistry13.95×3 works
  3. Nursing5.70×0 works
  4. Dentistry5.18×0 works
  5. Agricultural and Biological Sciences2.55×1 works
  6. Biochemistry, Genetics and Molecular Biology2.22×1 works
  7. Medicine1.20×3 works
  8. Materials Science0.80×0 works
  9. Immunology and Microbiology0.56×0 works

Who are the top researchers at Kane Biotech (Canada)?

Ranked on the quality score, Srinivasa Madhyastha, Miloslav Sailer and Purushottam V. Gawande lead among researchers whose main affiliation is Kane Biotech (Canada).

  1. 1 Srinivasa Madhyastha Canada · #1,207,893 worldwide 1.4k citations · 20 works
  2. 2 Miloslav Sailer Canada · #1,908,545 worldwide 469 citations · 19 works
  3. 3 Purushottam V. Gawande Canada · #2,089,291 worldwide 1.2k citations · 21 works
  4. 4 Nandadeva Yakandawala Canada · #2,144,631 worldwide 1.1k citations · 19 works
All ranked researchers at Kane Biotech (Canada)

What are the most cited papers from Kane Biotech (Canada)?

The most cited paper from Kane Biotech (Canada) is "Rice endosperm iron biofortification by targeted and synergistic action of nicotianamine synthase and ferritin" (Judith Wirth, Susanna Poletti, Beat Aeschlimann et al., 2009), with 322 citations. Next come "Antimicrobial and antibiofilm efficacy of triclosan and DispersinB(R) combination" (211) and "Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci" (203).

Most cited papers
#PaperReleasedCitations
1 Rice endosperm iron biofortification by targeted and synergistic action of nicotianamine synthase and ferritin Judith Wirth, Susanna Poletti, Beat Aeschlimann et al. · Plant Biotechnology Journal Open access 20 Jul 2009 322
2 Antimicrobial and antibiofilm efficacy of triclosan and DispersinB(R) combination Rabih O. Darouiche, Mohammad D. Mansouri, Purushottam V. Gawande et al. · Journal of Antimicrobial Chemotherapy 14 May 2009 211
3 Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci Jeffrey B. Kaplan, Karen LoVetri, Silvia T. Cardona et al. · The Journal of Antibiotics Open access 14 Dec 2011 203
4 A microplate spectrofluorometric assay for bacterial biofilms Euan Burton, Nandadeva Yakandawala, Karen LoVetri et al. · Journal of Industrial Microbiology & Biotechnology Open access 6 Feb 2006 152
5 Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism Eric C. H. Yip, Anthony S.L. Chan, H. W. Pang et al. · Cell Biology and Toxicology Jul 2006 136
All 47 most cited papers, with filters and sorting

Which keywords describe research at Kane Biotech (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Polymeric Materials, Antibiotic Resistance, Extracellular Matrix, Bacteria, Biofilms, Biomedical Applications, Antioxidant and Antioxidant Activity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Polymeric Materials3▲ 167×2 topics
  2. Antibiotic Resistance3▲ 24×4 topics
  3. Extracellular Matrix2▲ 38×2 topics
  4. Bacteria2▲ 183×1 topic
  5. Biofilms2▲ 156×1 topic
  6. Biomedical Applications2▲ 7.0×6 topics
  7. Epidemiology2▲ 1.87×9 topics
  8. Antioxidant2▲ 10×6 topics
  9. Antioxidant Activity2▲ 12×8 topics
  10. Inflammation2▲ 2.8×9 topics
  11. Antibacterial Agents2▲ 79×2 topics
  12. Antimicrobial Polymers2▲ 446×1 topic
  13. Quaternary Ammonium Compounds2▲ 238×1 topic
  14. Diabetes1▲ 9.7×3 topics
  15. Cyclodextrins1▲ 208×1 topic
  16. Herbal Medicine1▲ 21×4 topics
  17. Heterocyclic Compounds1▲ 30×2 topics
  18. Microbial Ecology1▲ 29×2 topics
  19. Solid Dispersions1▲ 208×1 topic
  20. Tissue Engineering1▲ 8.9×4 topics
  21. Anti-inflammatory1▲ 16×4 topics
  22. Host Defense1▲ 65×3 topics
  23. Angiogenesis1▲ 9.7×3 topics
  24. Anticancer Agents1▲ 15×2 topics
  25. Antimicrobial Peptides1▲ 78×2 topics
  26. Biomaterials1▲ 20×3 topics
  27. Cancer1▲ 2.8×4 topics
  28. Innate Immunity1▲ 11×3 topics
  29. Medicinal Plants1▲ 10×5 topics
  30. Pharmacology1▲ 12×4 topics
  31. Wound Healing1▲ 17×2 topics
  32. Medicinal Chemistry1▲ 9.6×1 topic
  33. Phytochemistry1▲ 29×3 topics
  34. Rheological Properties1▲ 23×2 topics
  35. Traditional Chinese Medicine1▲ 23×3 topics
  36. Tubulin Inhibitors1▲ 68×1 topic

Which research topics does Kane Biotech (Canada) publish most on?

By volume in 2022-now: Drug Solubulity and Delivery Systems, Synthesis and biological activity, Polysaccharides Composition and Applications and Marine Sponges and Natural Products.

  1. 1 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
  2. 2 Synthesis and biological activity Organic Chemistry 1 works
  3. 3 Polysaccharides Composition and Applications Food Science 1 works
  4. 4 Marine Sponges and Natural Products Biotechnology 1 works
  5. 5 Antimicrobial agents and applications Organic Chemistry 1 works
  6. 6 Wound Healing and Treatments Rehabilitation 1 works
  7. 7 Hydrogels: synthesis, properties, applications Molecular Medicine 0 works
  8. 8 Click Chemistry and Applications Organic Chemistry 0 works
  9. 9 Silymarin and Mushroom Poisoning Pulmonary and Respiratory Medicine 0 works
  10. 10 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.2%not open35.8%

World: 40% of research is openly available.

with international co-authors37.7%domestic only62.3%

World: 18% is written across borders.

How has Kane Biotech (Canada)'s research output changed?

Output in 2022-2025 was 37% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Kane Biotech (Canada) as a percentage of every work published that year, 0.000031% in 2024.

still counting0.000050%0.00010%0.00015%Kane Biotech (Canada)0.0000043% in 2025200020102020

Fractional works of Kane Biotech (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Winnipeg

All research institutions in Winnipeg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Kane Biotech (Canada). Posts are plain text and can be reported.